Download This PaperCompulsory Licensing of Pharmaceutical Patents in India: A Policy Shift
Economic and Political Weekly 54 (5), 12-15, 2019
4 Pages Posted: 26 May 2020
Date Written: February 2, 2019
Abstract
The trend of the continued rejection of compulsory licence applications in India goes against the local generic drug manufacturers and public health safeguards incorporated in the Indian patent law. It raises serious questions about the intervening role of the state in patent monopoly to equalise the competing interests between patent holders and consumers of “public good.” This trend indicates a policy shift of the government regarding compulsory licensing.
Keywords: Compulsory Licensing, Access to medicine, Patents, Pharmaceutical, TRIPS, WTO.
Suggested Citation: Suggested Citation
Saha, Prabhat Kumar, Compulsory Licensing of Pharmaceutical Patents in India: A Policy Shift (February 2, 2019). Economic and Political Weekly 54 (5), 12-15, 2019, Available at SSRN: https://ssrn.com/abstract=3586240
Do you have a job opening that you would like to promote on SSRN?
Feedback
Feedback to SSRN